Titan Biotech Board Meeting on 30 May 2026 to Approve Results

Titan Biotech Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results (standalone and consolidated) for the financial year ended March 31, 2026. The board will also consider recommending a dividend on equity shares, if any. The trading window has been closed from April 1, 2026, and will remain closed until 48 hours after the board meeting outcome.